Die Forschung
Abteilung I
Entwicklung und Umbau des HerzensProf. Dr. Dr. Thomas Braun
Abteilung II
PharmakologieProf. Dr. Stefan Offermanns
Abteilung III
Genetik der EntwicklungDr. Didier Stainier
Abteilung IV
Entwicklung und Umbau der LungeProf. Dr. Werner Seeger
Informationen für
Anmelden
Sofja Kovalevskaja Research Group: Publications
Former and current lab members are highlighted in bold:
Patra C, Talukdar S, Novoyatleva T, Velagala SR, Mühlfeld C, Kundu B, Kundu SC, Engel FB: Silk protein fibroin from Antheraea mylitta for cardiac tissue engineering. Biomaterials. 2012; 33:2673-80.
Patra C, Diehl F, Ferrazzi F, van Amerongen MJ, Novoyatleva T, Schaefer L, Mühlfeld C, Jungblut B, Engel FB: Nephronectin regulates via BMP4-HAS2 signaling the differentiation of the atrio-ventricular canal in zebrafish. Development. 2011; 138(20):4499-509.
Diehl F, Brown MA, van Amerongen MJ, Novoyatleva T, Wietelmann A, Harriss J, Ferrazzi F, Böttger T, Harvey RP, Tucker PW, Engel FB: Cardiac deletion of Smyd2 is dispensable for mouse heart development.
PLoS ONE. 2010; 5(3):e9748.
van Amerongen MJ, Diehl F, Novoyatleva T, Patra C, Engel FB: E2F4 is required for cardiomyocyte proliferation. Cardiovasc Res. 2010; 86(1):92-102.
Novoyatleva T, Diehl F, van Amerongen MJ, Patra C, Ferrazzi F, Bellazzi R, Engel FB: TWEAK is a positive regulator of cardiomyocyte proliferation. Cardiovasc Res. 2010; 85(4):681-90.
Simonides WS, Mulcahey MA, Redout EM, Muller A, Zuidwijk MJ, Visser TJ, Wassen FWJS, Crescenzi A, da-Silva WS, Harney J, Engel FB, Obregon MJ, Larsen PR, Bianco AC, Huang SA: Hypoxia-inducible factor induces local thyroid hormone inactivation in hypoxic-ischemic disease.
J Clin Invest. 2008;118(3):975-983.
Engel FB, Hsieh PCH, Lee RT, Keating MT: FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring and rescues function after myocardial infarction. Proc Natl Acad Sci U S A. 2006; 103(42):15546-51. (supporting information)
Tseng AS, Engel FB, Keating MT: The GSK-3 Inhibitor BIO Promotes Proliferation in Mammalian Cardiomyocytes. Chemistry & Biology. 2006; 13(9):957-63. (supplemental data)
Engel FB, Schebesta M, Keating MT: Anillin Localization Defect in Cardiomyocyte Binucleation. J Mol Cell Cardiol, 2006; 41(4):601-612 (Cover, Editorial).
Schebesta M, Lien CL, Engel FB, Keating MT: Transcriptional Profiling of Caudal Fin Regeneration in Zebrafish. Scientific World Journal Development & Embryology. 2006; 1(S1):38-54.
Engel FB, Schebesta M, Duong MT, Lu G, Ren S, Madwed JB, Jiang H, Wang Y, Keating MT: p38 MAP Kinase Inhibition Enables Proliferation of Adult Mammalian Cardiomyocytes. Genes & Dev.2005; 19(10):1175-87. (supplemental research data)
Philippar U, Schratt G, Dieterich C, Muller JM, Galgoczy P, Engel FB, Keating MT, Gertler F, Schule R, Vingron M, Nordheim A: The SRF Target Gene Fhl2 Antagonizes RhoA/MAL-Dependent Activation of SRF. Mol Cell. 2004; 16(6):867-80.
Gresch O, Engel FB, Nesic D, Tran TT, England HM, Hickman ES, Körner I, Gan L, Chen S, Castro-Obregon S, Hammermann R, Wolf J, Müller-Hartmann H, Nix M, Siebenkotten G, Kraus G, Lun K: New non-viral method for gene transfer into primary cells. Methods, 2004; 33(2):151-63.
Engel FB, Hauck L, Boehm M, Nabel EG, Dietz R, von Harsdorf R: P21CIP1 controls proliferating cell nuclear antigen protein level in adult cardiomyocytes. Mol Cell Biol. 2003; 23(2):555-65.
Engel FB, Hauck L, Cardoso MC, Leonhardt H, Dietz R, von Harsdorf R: A mammalian myocardial cell-free system to study cell cycle reentry in terminally differentiated cardiomyocytes. Circ Res. 1999; 85(3):294-301.
Reviews:
Engel FB: Cardiomyocyte Proliferation: A Platform for Mammalian Cardiac Repair. Cell Cycle. 2005; 4:1360-63.
van Amerongen MJ and Engel FB: Features of cardiomyocyte proliferation and its potential for cardiac regeneration. See van Amerongen MJ 2008 for the pre-peer-reviewed version of the article above, which has been published in final form at J Cell Mol Med. 2008; 12(6a):2233-44.


